Abzena, a CDMO for complex biologics and bioconjugates announced a significant expansion of its quality control (QC) testing capabilities at their San Diego, CA biologics development and cGMP manufacturing site. The new lab space enhances Abzena’s existing analytical services for antibodies with rapid microbiology release testing and improved scalability through advanced materials separation.     The new microbiology lab was designed as a standalone space to separate product testing from all o...